American Urological Association Releases Non-Muscle Invasive Bladder Cancer Guideline Amendment

The American Urological Association (AUA), in partnership with the Society of Urologic Oncology (SUO), has released a 2026 amendment to its guideline for the diagnosis and treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). The updated guidance incorporates the latest evidence, including new recommendations on bladder-preserving therapies and disease monitoring, with an emphasis on individualized patient care.